Skip to search formSkip to main contentSkip to account menu

delamanid

National Institutes of Health

Related topics

Related topics

1 relation
OPC-67683

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.
Two new drugs, delamanid and bedaquiline, have recently been approved for treatment of multidrug-resistant and extensively drug… 
Review
2018
Review
2018
Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Review
2018
Review
2018
Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.
Review
2018
Review
2018
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
Background An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to… 
Highly Cited
2018
Highly Cited
2018
Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea
Relatively little is known about the efficacy and safety of the programmatic use of bedaquiline and delamanid in multidrug… 
Highly Cited
2017
Highly Cited
2017
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective…
Review
2017
Review
2017
Recent advancements in the development of anti-tuberculosis drugs.
2017
2017
Delamanid Kills Dormant Mycobacteria In Vitro and in a Guinea Pig Model of Tuberculosis
ABSTRACT Tuberculosis (TB) treatment is long and requires multiple drugs, likely due to various phenotypes of TB bacilli with… 
Review
2017
Review
2017
Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.
The new drugs delamanid and bedaquiline are increasingly used to treat multidrug-resistant (MDR-) and extensively drug-resistant… 
Highly Cited
2016
Highly Cited
2016
Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
OBJECTIVES The objective of this study was to develop standardized protocols for rapid delamanid drug susceptibility testing (DST… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)